What is the total amount of Wegovy (semaglutide) needed for a 90-day supply at a dose of 2.4mg weekly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Wegovy 90-Day Supply Calculation

For a patient on Wegovy 2.4 mg weekly maintenance dose, dispense 13 single-dose pens (2.4 mg/0.75 mL each) for a 90-day supply.

Dosing Calculation

  • Wegovy is administered once weekly at the maintenance dose of 2.4 mg 1, 2
  • For a 90-day supply: 90 days ÷ 7 days/week = approximately 12.86 weeks, which rounds to 13 doses 1
  • Each pen contains a single dose of 2.4 mg/0.75 mL 1
  • Total dispense: 13 pens of Wegovy 2.4 mg/0.75 mL 1

Important Clinical Context

Maintenance Dosing Considerations

  • The 2.4 mg weekly dose is the maintenance dose reached after a 16-week titration schedule starting at 0.25 mg weekly 1, 2
  • The titration schedule progresses: 0.25 mg (weeks 1-4) → 0.5 mg (weeks 5-8) → 1.0 mg (weeks 9-12) → 1.7 mg (weeks 13-16) → 2.4 mg (week 17 onwards) 1, 2
  • Gradual titration is essential to minimize gastrointestinal adverse effects, which are the most common side effects 1, 2

Missed Dose Protocol

  • If less than 5 days since missed dose: administer as soon as possible 1, 2
  • If more than 5 days have passed: skip the missed dose and resume regular schedule 1, 2
  • If 2 consecutive doses missed: consider resuming at same dose if previously well-tolerated, or lower the dose based on clinical judgment 1, 2
  • If 3 or more consecutive doses missed: consider restarting the titration schedule 1

Storage and Administration

  • Store in refrigerator (36°F to 46°F/2°C to 8°C); may be kept at room temperature for up to 28 days 1
  • Can be administered at any time of day, with or without meals 1, 2

Clinical Efficacy Context

  • At 68 weeks, semaglutide 2.4 mg achieved mean weight loss of 14.9% versus 2.4% with placebo 3, 4
  • 86.4% of patients achieved ≥5% weight loss, and 50.5% achieved ≥15% weight loss 4
  • Long-term use is necessary: after cessation, patients regained 11.6% of lost weight over 52 weeks 3

References

Guideline

Recommended Dosing Regimen for Wegovy (Semaglutide)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Semaglutide Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Once-Weekly Semaglutide in Adults with Overweight or Obesity.

The New England journal of medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.